Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia

Journal of Urology

Volumn 186, Issue 3, 2011, Pages 977-981

  Chung, Doreen E ^a   Wysock, James S ^b   Lee, Richard K ^b   Melamed, Scott R ^b   Kaplan, Steven A ^b   Te, Alexis E ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

anticoagulants; laser therapy; prostate; prostatic hyperplasia; transurethral resection of prostate

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; INFUSION FLUID; PROSTATE SPECIFIC ANTIGEN; SODIUM; VON WILLEBRAND FACTOR; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ANTIGEN DETECTION; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; CATHETERIZATION; COMORBIDITY; CONGESTIVE HEART FAILURE; DEMOGRAPHY; ENERGY CONSUMPTION; FLOW RATE; FOLLOW UP; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER PROSTATECTOMY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REOPERATION; SODIUM BLOOD LEVEL; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE RETENTION; VAPORIZATION; VON WILLEBRAND DISEASE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 80051548284     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.04.068     Document Type: Article

References (12)

1. A. Descazeaud, G. Robert, and A. Azzousi Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review BJU Int 103 2008 1162
2. J. Rassweiler, D. Teber, and R. Kuntz Complications of transurethral resection of the prostate (TURP)incidence, management, and prevention Eur Urol 50 2006 969
3. K. Horasanli, M. Silay, and B. Altay Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial Urology 71 2008 247
4. M. Charlson, T. Szatrowski, and J. Peterson Validation of a combined comorbidity index J Clin Epidemiol 47 1994 1245
5. N. Parr, C. Loh, and A. Desmond Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy Br J Urol 64 1989 623
6. A. Descazeaud, G. Robert, and S. Lebdai Impact of oral anticoagulation on morbidity of transurethral resection of the prostate World J Urol 29 2011 211
7. K. Okamura, Y. Nojiri, and I.N. Sek Perioperative management of transurethral surgery for benign prostatic hyperplasia: a nationwide survey in Japan Int J Urol 18 2011 304
8. J. Sandhu, C. Ng, and R. Gonzalez Photoselective laser vaporization prostatectomy in men receiving anticoagulants J Endourol 19 2005 1196
9. C. Jeldres, H. Isbarn, and U. Capitanio Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia J Urol 182 2009 626
10. H. Isbarn, C. Jeldres, and U. Capitanio Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy J Endourol 23 2009 1347
11. O. Reich, A. Bachmann, and M. Siebels High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients J Urol 173 2005 158
12. R. Ruszat, S. Wyler, and T. Forster Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation Eur Urol 51 2007 1031